“Expired Patents, Trade Secrets, and Stymied Competition”

  • Law and Technology
  • Health Law
Notre Dame Law Review
2017

“Privacy and Accountability in Black-Box Medicine”

  • Law and Technology
  • Health Law
Michigan Telecommunications and Technology Law Review
2016

“Big Data, Patents, and the Future of Medicine”

  • Law and Technology
  • Health Law
Cardozo Law Review
2016

“Regulating Secrecy”

  • Law and Technology
  • Health Law
Washington Law Review
2016

“Codon Influence on Large-Scale Protein Expression Correlates with E. coli mRNA Levels”

  • Law and Technology
  • Health Law
Nature
2016

“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”

  • Law and Technology
  • Health Law
Journal of Diabetes Science and Technology
2016

“Black-Box Medicine”

  • Law and Technology
  • Health Law
Harvard Journal of Law & Technology
2015

“Innovation Policy Failures in the Manufacturing of Drugs”

  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Introduction to ‘Timing is Everything: Balancing Access and Uncertainty’ ”

  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Are Trade Secrets Delaying Biosimilars?”

  • Law and Technology
  • Health Law
Science
2015

“Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?”

  • Law and Technology
  • Health Law
Nature Biotechnology
2015

“Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing”

  • Law and Technology
  • Health Law
IP Theory
2014

“Nudging the FDA”

  • Law and Technology
  • Health Law
The American Interest
2014

“Informed Consent for Return of Incidental Findings in Genomic Research”

  • Law and Technology
  • Health Law
Genetics in Medicine
2013

“Problems of Innovation-Deficient Pharmaceutical Manufacturing”

  • Law and Technology
  • Health Law
New England Journal of Medicine
2013

“Legal Implications of an Ethical Duty to Search for Genetic Incidental Findings”

The American Journal of Bioethics
2013

“Unblocked Future: Why Gene Patents Won’t Hinder Whole-Genome Sequencing and Personalized Medicine”

  • Law and Technology
  • Health Law
Cardozo Law Review
2012

“Large-Scale Experimental Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. coli”

  • Law and Technology
  • Health Law
Microbial Informatics and Experimentation
2011

“The Deepwater Horizon Oil Spill: Potential Insurance Coverage Implications”

  • Law and Technology
  • Health Law
Insurance Coverage Law Bulletin
2010

“Understanding the Physical Properties that Control Protein Crystallization by Analysis of Large-Sale Experimental Data”

  • Law and Technology
  • Health Law
Nature Biotechnology
2009

“Patenting Race: The Problems of Ethnic Genetic Testing Patents”

  • Law and Technology
  • Health Law
Columbia Science and Technology Law Review
2007

“MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity”

  • Law and Technology
  • Health Law
Molecular Diagnosis
2003

Innovation Institutions and COVID-19

  • Law and Technology
  • Health Law

“Liability for Use of Artificial Intelligence in Medicine”

  • Law and Technology
  • Health Law
Research Handbook on Health, AI and the Law

Innovation Institutions and COVID-19, Part II

“Cryptic Patent Reform Through the Inflation Reduction Act”

Harvard Journal of Law and Technology

“Health AI, System Performance, and Physicians in the Loop”

The Economics of Artificial Intelligence: Health Care Challenges

“Legal Processes Required to Implement AI in Healthcare”

Artificial Intelligence and Machine Learning in Healthcare

“Rethinking Innovation at FDA”

Boston University Law Review